| Followers | 236 |
| Posts | 10817 |
| Boards Moderated | 0 |
| Alias Born | 07/17/2006 |
Sunday, August 11, 2019 8:37:24 AM
LBL...
Stick to being an actuary (the numbers). When it comes to speculation you are in over your head...MRC is the child of one very sick and not particularly bright individual...A guy who renovates bathrooms..A guy who was premed and never got into med school. And can not live with that fact.
You, my son and I all worry about AZN, a criminal enterprise masquerading as a biotech..But are they stupid enough to get in the ring with Amarin..Amarin of little body but mighty heart..Ganging up with a bathroom installer with some serious metal issues..Amarin might be a small biotech..But it knows how to win in court where it is undefeated against the FDA...
Ask yourself...how was Amarin smart enough to pull off a $450mil strategic cash raise just before FDA hit them with the AdCom announcement and a delay in the sNDA date...The only way they could have possibly known FDA was going to pull the rug out was Amarin had a mole in the FDA...These FOIA requests must have a chilling effect on FDA...and if any of this is related to AZN then conspiracy charges will be filed..This could turn out to be one hell of a story..Amarin could end up owning AZN (if that's what they want)..I'm thinking AZN is not that stupid..
This is all conjecture...things never turn out the way you think they will..The future is such a slut...
":>) JL
Stick to being an actuary (the numbers). When it comes to speculation you are in over your head...MRC is the child of one very sick and not particularly bright individual...A guy who renovates bathrooms..A guy who was premed and never got into med school. And can not live with that fact.
You, my son and I all worry about AZN, a criminal enterprise masquerading as a biotech..But are they stupid enough to get in the ring with Amarin..Amarin of little body but mighty heart..Ganging up with a bathroom installer with some serious metal issues..Amarin might be a small biotech..But it knows how to win in court where it is undefeated against the FDA...
Ask yourself...how was Amarin smart enough to pull off a $450mil strategic cash raise just before FDA hit them with the AdCom announcement and a delay in the sNDA date...The only way they could have possibly known FDA was going to pull the rug out was Amarin had a mole in the FDA...These FOIA requests must have a chilling effect on FDA...and if any of this is related to AZN then conspiracy charges will be filed..This could turn out to be one hell of a story..Amarin could end up owning AZN (if that's what they want)..I'm thinking AZN is not that stupid..
This is all conjecture...things never turn out the way you think they will..The future is such a slut...
":>) JL
Recent AMRN News
- Earnings Report Shows Narrowing Losses as Amarin (AMRN) Advances Partner-Led Growth Strategy • IH Market News • 04/29/2026 02:19:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/29/2026 11:06:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/29/2026 11:05:15 AM
- Amarin Reports 2026 First Quarter Financial Results • GlobeNewswire Inc. • 04/29/2026 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/22/2026 09:00:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:03 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/21/2026 09:00:02 PM
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
